Fine mapping and candidate gene analysis of Dravet syndrome modifier loci on mouse chromosomes 7 and 8
- PMID: 38862622
- PMCID: PMC11329421
- DOI: 10.1007/s00335-024-10046-3
Fine mapping and candidate gene analysis of Dravet syndrome modifier loci on mouse chromosomes 7 and 8
Abstract
Dravet syndrome is a developmental and epileptic encephalopathy (DEE) characterized by intractable seizures, comorbidities related to developmental, cognitive, and motor delays, and a high mortality burden due to sudden unexpected death in epilepsy (SUDEP). Most Dravet syndrome cases are attributed to SCN1A haploinsufficiency, with genetic modifiers and environmental factors influencing disease severity. Mouse models with heterozygous deletion of Scn1a recapitulate key features of Dravet syndrome, including seizures and premature mortality; however, severity varies depending on genetic background. Here, we refined two Dravet survival modifier (Dsm) loci, Dsm2 on chromosome 7 and Dsm3 on chromosome 8, using interval-specific congenic (ISC) mapping. Dsm2 was complex and encompassed at least two separate loci, while Dsm3 was refined to a single locus. Candidate modifier genes within these refined loci were prioritized based on brain expression, strain-dependent differences, and biological relevance to seizures or epilepsy. High priority candidate genes for Dsm2 include Nav2, Ptpn5, Ldha, Dbx1, Prmt3 and Slc6a5, while Dsm3 has a single high priority candidate, Psd3. This study underscores the complex genetic architecture underlying Dravet syndrome and provides insights into potential modifier genes that could influence disease severity and serve as novel therapeutic targets.
© 2024. The Author(s).
Conflict of interest statement
JAK serves on the Scientific Advisory Boards of the Dravet Syndrome Foundation and FamilieSCN2A Foundation. JAK receives research funding from Praxis Precision Medicines and Neurocrine Biosciences. NAH provides paid consulting services to Takeda Pharmaceuticals. All other authors have declared that no competing interests exist.
Figures
Update of
-
Fine Mapping and Candidate Gene Analysis of Dravet Syndrome Modifier Loci on Mouse Chromosomes 7 and 8.bioRxiv [Preprint]. 2024 Apr 18:2024.04.15.589561. doi: 10.1101/2024.04.15.589561. bioRxiv. 2024. Update in: Mamm Genome. 2024 Sep;35(3):334-345. doi: 10.1007/s00335-024-10046-3. PMID: 38659879 Free PMC article. Updated. Preprint.
Similar articles
-
Fine Mapping and Candidate Gene Analysis of Dravet Syndrome Modifier Loci on Mouse Chromosomes 7 and 8.bioRxiv [Preprint]. 2024 Apr 18:2024.04.15.589561. doi: 10.1101/2024.04.15.589561. bioRxiv. 2024. Update in: Mamm Genome. 2024 Sep;35(3):334-345. doi: 10.1007/s00335-024-10046-3. PMID: 38659879 Free PMC article. Updated. Preprint.
-
Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq.PLoS Genet. 2016 Oct 21;12(10):e1006398. doi: 10.1371/journal.pgen.1006398. eCollection 2016 Oct. PLoS Genet. 2016. PMID: 27768696 Free PMC article.
-
Mapping genetic modifiers of survival in a mouse model of Dravet syndrome.Genes Brain Behav. 2014 Feb;13(2):163-72. doi: 10.1111/gbb.12099. Epub 2013 Nov 14. Genes Brain Behav. 2014. PMID: 24152123 Free PMC article.
-
Genetic therapeutic advancements for Dravet Syndrome.Epilepsy Behav. 2022 Jul;132:108741. doi: 10.1016/j.yebeh.2022.108741. Epub 2022 May 30. Epilepsy Behav. 2022. PMID: 35653814 Review.
-
Dravet syndrome as part of the clinical and genetic spectrum of sodium channel epilepsies and encephalopathies.Epilepsia. 2019 Dec;60 Suppl 3:S2-S7. doi: 10.1111/epi.16054. Epilepsia. 2019. PMID: 31904125 Review.
References
-
- Accogli A, Lu S, Musante I, Scudieri P, Rosenfeld JA, Severino M, Baldassari S, Iacomino M, Riva A, Balagura G, Piccolo G, Minetti C, Roberto D, Xia F, Razak R, Lawrence E, Hussein M, Chang EY, Holick M, Calì E, Aliberto E, De-Sarro R, Gambardella A, UD Network, SS Group, Emrick L, McCaffery PJA, Clagett-Dame M, Marcogliese PC, Bellen HJ, Lalani SR, Zara F, Striano P, Salpietro V (2023) Loss of neuron navigator 2 impairs brain and cerebellar development. Cerebellum 22:206–222 10.1007/s12311-022-01379-3 - DOI - PMC - PubMed
-
- Baldarelli RM, Smith CM, Finger JH, Hayamizu TF, McCright IJ, Xu J, Shaw DR, Beal JS, Blodgett O, Campbell J, Corbani LE, Frost PJ, Giannatto SC, Miers DB, Kadin JA, Richardson JE, Ringwald M (2021) The mouse gene expression database (GXD): 2021 update. Nucleic Acids Res 49:D924-d931 10.1093/nar/gkaa914 - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous